Symbols / MENS Stock $2.19 -3.52% Jyong Biotech Ltd.

Healthcare • Biotechnology • Taiwan • NGM
MENS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Ms. Fu-Feng Kuo
Exch · Country NGM · Taiwan
Market Cap 166.50M
Enterprise Value 175.34M
Income -2.94M
Sales —
FCF (ttm) —
Book/sh -0.31
Cash/sh 0.24
Employees —
Insider 10d —
IPO Jun 17, 2025
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S —
P/B -7.00
P/C —
EV/EBITDA -97.25
EV/Sales —
Quick Ratio 0.62
Current Ratio 0.62
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -0.04
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA -5.44%
ROE —
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 74.23M
Shs Float 27.63M
Insider Own 62.21%
Instit Own 1.03%
Short Float 0.32%
Short Ratio 0.76
Short Interest 133.02K
52W High 67.00
vs 52W High -96.73%
52W Low 1.43
vs 52W Low 53.15%
Beta —
Impl. Vol. 25.00%
Rel Volume 0.23
Avg Volume 272.25K
Volume 61.50K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $2.27
Price $2.19
Change -3.52%
About

Jyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops MCS-2 for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$2.19
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
$2.19
Low
—
High
—
Mean
—
News
RSS: Latest MENS news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
2.06
-26.49%
2.80
-1.13%
2.83
+17.68%
2.40
Research And Development
0.93
-13.45%
1.07
-16.98%
1.29
-17.25%
1.56
Selling General And Administration
1.13
-34.59%
1.73
+12.15%
1.54
+82.13%
0.84
Selling And Marketing Expense
0.04
-6.38%
0.05
+0.00%
0.05
-12.96%
0.05
General And Administrative Expense
1.08
-35.38%
1.68
+12.53%
1.49
+88.62%
0.79
Other Gand A
1.08
-35.38%
1.68
+12.53%
1.49
+88.62%
0.79
Total Expenses
2.06
-26.49%
2.80
-1.13%
2.83
+17.68%
2.40
Operating Income
-2.06
+26.49%
-2.80
+1.13%
-2.83
-17.68%
-2.40
Total Operating Income As Reported
-2.06
+26.49%
-2.80
+1.13%
-2.83
-17.68%
-2.40
EBITDA
-1.86
+46.99%
-3.52
+38.77%
-5.74
-77.17%
-3.24
Normalized EBITDA
-1.86
+46.99%
-3.52
+38.77%
-5.74
-77.17%
-3.24
Reconciled Depreciation
0.12
-5.51%
0.13
+3.25%
0.12
+0.82%
0.12
EBIT
-1.98
+45.54%
-3.64
+37.89%
-5.87
-74.40%
-3.36
Net Income
-3.02
+31.39%
-4.40
+33.63%
-6.63
-57.93%
-4.20
Pretax Income
-3.02
+31.39%
-4.40
+33.63%
-6.63
-57.93%
-4.20
Net Non Operating Interest Income Expense
-1.03
-46.65%
-0.70
+7.76%
-0.76
+8.32%
-0.83
Interest Expense Non Operating
1.03
+36.72%
0.76
-1.05%
0.77
-8.38%
0.83
Net Interest Income
-1.03
-46.65%
-0.70
+7.76%
-0.76
+8.32%
-0.83
Interest Expense
1.03
+36.72%
0.76
-1.05%
0.77
-8.38%
0.83
Interest Income Non Operating
0.01
-87.50%
0.06
+1020.00%
0.01
-16.67%
0.01
Interest Income
0.01
-87.50%
0.06
+1020.00%
0.01
-16.67%
0.01
Other Income Expense
0.07
+107.21%
-0.90
+70.34%
-3.04
-215.13%
-0.96
Other Non Operating Income Expenses
0.07
+107.21%
-0.90
+70.34%
-3.04
-215.13%
-0.96
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-3.02
+31.39%
-4.40
+33.63%
-6.63
-57.93%
-4.20
Net Income From Continuing Operation Net Minority Interest
-3.02
+31.39%
-4.40
+33.63%
-6.63
-57.93%
-4.20
Net Income From Continuing And Discontinued Operation
-3.02
+31.39%
-4.40
+33.63%
-6.63
-57.93%
-4.20
Net Income Continuous Operations
-3.02
+31.39%
-4.40
+33.63%
-6.63
-57.93%
-4.20
Normalized Income
-3.02
+31.39%
-4.40
+33.63%
-6.63
-57.93%
-4.20
Net Income Common Stockholders
-3.02
+31.39%
-4.40
+33.63%
-6.63
-57.93%
-4.20
Diluted EPS
-0.04
+31.39%
-0.06
+33.63%
-0.09
-57.93%
-0.06
Basic EPS
-0.04
+31.39%
-0.06
+33.63%
-0.09
-57.93%
-0.06
Basic Average Shares
76.03
+0.00%
76.03
+0.00%
76.03
+0.00%
76.03
Diluted Average Shares
76.03
+0.00%
76.03
+0.00%
76.03
+0.00%
76.03
Diluted NI Availto Com Stockholders
-3.02
+31.39%
-4.40
+33.63%
-6.63
-57.93%
-4.20
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
6.37
-22.82%
8.25
-5.68%
8.74
-7.28%
9.43
Current Assets
0.21
-88.80%
1.84
-25.33%
2.46
-6.99%
2.65
Cash Cash Equivalents And Short Term Investments
0.10
-44.63%
0.18
-78.20%
0.81
-65.95%
2.38
Cash And Cash Equivalents
0.10
-44.63%
0.18
-75.35%
0.72
+30.31%
0.55
Cash Equivalents
0.10
-44.89%
0.18
-75.38%
0.71
+30.00%
0.55
Cash Financial
0.00
+0.00%
0.00
-66.67%
0.00
+200.00%
0.00
Other Short Term Investments
—
0.00
-100.00%
0.09
-94.87%
1.83
Restricted Cash
0.00
-99.81%
1.56
+0.58%
1.56
0.00
Other Current Assets
0.10
+8.25%
0.10
+2.11%
0.10
-63.88%
0.26
Total Non Current Assets
6.16
-3.89%
6.41
+2.02%
6.28
-7.40%
6.78
Net PPE
3.19
-10.10%
3.54
-40.92%
6.00
-11.47%
6.78
Gross PPE
4.76
-6.74%
5.11
-31.24%
7.43
-9.73%
8.23
Accumulated Depreciation
-1.58
-0.90%
-1.56
-9.46%
-1.43
+1.59%
-1.45
Properties
0.00
0.00
0.00
0.00
Land And Improvements
0.95
-6.67%
1.02
+0.39%
1.02
-9.77%
1.13
Buildings And Improvements
2.48
-6.60%
2.65
+0.38%
2.64
-9.74%
2.93
Machinery Furniture Equipment
0.13
-6.99%
0.14
+0.70%
0.14
-9.55%
0.16
Construction In Progress
0.14
-2.88%
0.14
-3.47%
0.14
+336.36%
0.03
Other Properties
0.93
-7.68%
1.00
-69.91%
3.33
-14.91%
3.92
Leases
0.14
-6.67%
0.15
+0.00%
0.15
+123.88%
0.07
Non Current Deferred Assets
0.93
+29.54%
0.72
+161.23%
0.28
0.00
Other Non Current Assets
2.04
-4.85%
2.14
+30528.57%
0.01
-12.50%
0.01
Total Liabilities Net Minority Interest
42.88
+1.33%
42.32
+10.28%
38.38
+17.15%
32.76
Current Liabilities
12.13
-14.95%
14.26
+10.47%
12.91
+105.07%
6.29
Payables And Accrued Expenses
1.36
+17.04%
1.16
+33.41%
0.87
-19.94%
1.09
Payables
0.04
+91.30%
0.02
+187.50%
0.01
-83.33%
0.05
Accounts Payable
0.00
+50.00%
0.00
-50.00%
0.00
-91.30%
0.05
Current Accrued Expenses
1.32
+15.54%
1.14
+31.98%
0.86
-17.02%
1.04
Current Debt And Capital Lease Obligation
7.44
-8.16%
8.10
+3.63%
7.82
+50.84%
5.18
Current Debt
7.28
-8.66%
7.97
+4.24%
7.65
+55.04%
4.93
Other Current Borrowings
7.28
-8.66%
7.97
+4.24%
7.65
+55.04%
4.93
Current Capital Lease Obligation
0.16
+22.31%
0.13
-23.53%
0.17
-32.00%
0.25
Other Current Liabilities
3.33
-33.40%
4.99
+18.40%
4.22
+18239.13%
0.02
Total Non Current Liabilities Net Minority Interest
30.76
+9.60%
28.06
+10.18%
25.47
-3.76%
26.46
Long Term Debt And Capital Lease Obligation
10.69
+24.51%
8.59
+33.51%
6.43
-2.62%
6.61
Long Term Debt
10.68
+25.33%
8.52
+34.85%
6.32
+0.93%
6.26
Long Term Capital Lease Obligation
0.02
-76.81%
0.07
-40.00%
0.12
-66.76%
0.35
Tradeand Other Payables Non Current
0.00
0.00
0.00
0.00
Other Non Current Liabilities
19.44
+3.13%
18.85
+2.38%
18.41
-4.27%
19.23
Stockholders Equity
-36.52
-7.18%
-34.07
-14.99%
-29.63
-27.04%
-23.32
Common Stock Equity
-36.52
-7.18%
-34.07
-14.99%
-29.63
-27.04%
-23.32
Capital Stock
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Common Stock
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Share Issued
76.03
+0.00%
76.03
+0.00%
76.03
+0.00%
76.03
Ordinary Shares Number
76.03
+0.00%
76.03
+0.00%
76.03
+0.00%
76.03
Additional Paid In Capital
11.80
+0.00%
11.80
+0.00%
11.80
+0.00%
11.80
Retained Earnings
-33.08
-10.04%
-30.06
-17.15%
-25.66
-34.84%
-19.03
Gains Losses Not Affecting Retained Earnings
1.12
+104.56%
0.55
-7.12%
0.59
+121.80%
0.27
Treasury Stock
16.37
+0.00%
16.37
+0.00%
16.37
+0.00%
16.37
Other Equity Adjustments
1.12
+104.56%
0.55
-7.12%
0.59
+121.80%
0.27
Total Equity Gross Minority Interest
-36.52
-7.18%
-34.07
-14.99%
-29.63
-27.04%
-23.32
Total Capitalization
-25.84
-1.13%
-25.55
-9.61%
-23.31
-36.61%
-17.07
Working Capital
-11.92
+4.01%
-12.42
-18.91%
-10.44
-186.45%
-3.65
Invested Capital
-18.56
-5.56%
-17.58
-12.23%
-15.66
-29.12%
-12.13
Total Debt
18.14
+8.65%
16.69
+17.12%
14.25
+20.88%
11.79
Net Debt
17.86
+9.48%
16.32
+23.15%
13.25
+24.49%
10.64
Capital Lease Obligations
0.17
-12.06%
0.20
-30.18%
0.28
-52.18%
0.60
Net Tangible Assets
-36.52
-7.18%
-34.07
-14.99%
-29.63
-27.04%
-23.32
Tangible Book Value
-36.52
-7.18%
-34.07
-14.99%
-29.63
-27.04%
-23.32
Dueto Related Parties Current
0.04
+95.24%
0.02
+425.00%
0.00
+100.00%
0.00
Dueto Related Parties Non Current
0.63
+0.00%
0.63
+0.00%
0.63
+0.00%
0.63
Interest Payable
0.34
+21.63%
0.28
+22.61%
0.23
+52.32%
0.15
Line Of Credit
—
—
7.17
+50.67%
4.76
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-3.62
-39.33%
-2.60
+12.45%
-2.97
-49.75%
-1.98
Cash Flow From Continuing Operating Activities
-3.62
-39.33%
-2.60
+12.45%
-2.97
-49.75%
-1.98
Net Income From Continuing Operations
-3.02
+31.39%
-4.40
+33.63%
-6.63
-57.93%
-4.20
Depreciation Amortization Depletion
0.12
-5.51%
0.13
+3.25%
0.12
+0.82%
0.12
Depreciation
0.12
-5.51%
0.13
—
—
Depreciation And Amortization
0.12
-5.51%
0.13
+3.25%
0.12
+0.82%
0.12
Other Non Cash Items
0.76
+37.36%
0.55
-7.51%
0.60
-29.45%
0.85
Change In Working Capital
-1.49
-232.92%
1.12
-61.93%
2.94
+136.28%
1.24
Change In Prepaid Assets
-0.01
-300.00%
-0.00
-101.19%
0.17
+23.53%
0.14
Change In Payables And Accrued Expense
0.17
-42.52%
0.29
+243.41%
-0.20
-174.28%
0.28
Change In Accrued Expense
0.17
-43.24%
0.30
+267.23%
-0.18
-165.80%
0.27
Change In Payable
0.00
+150.00%
-0.00
+92.86%
-0.03
-500.00%
0.01
Change In Account Payable
0.00
+150.00%
-0.00
+92.86%
-0.03
-233.33%
0.02
Change In Other Current Assets
—
—
0.00
-100.00%
0.00
Change In Other Current Liabilities
-1.65
-299.39%
0.83
-72.23%
2.97
+258.75%
0.83
Investing Cash Flow
0.00
-100.00%
0.10
-93.18%
1.39
+206.50%
-1.31
Cash Flow From Continuing Investing Activities
0.00
-100.00%
0.10
-93.18%
1.39
+206.50%
-1.31
Net PPE Purchase And Sale
—
0.00
+100.00%
-0.25
-79.56%
-0.14
Purchase Of PPE
—
0.00
+100.00%
-0.25
-79.56%
-0.14
Capital Expenditure
—
—
-0.25
-79.56%
-0.14
Net Investment Purchase And Sale
0.00
-100.00%
0.10
-94.20%
1.64
+240.00%
-1.17
Purchase Of Investment
—
0.00
+100.00%
-0.29
+84.08%
-1.83
Sale Of Investment
0.00
-100.00%
0.10
-95.08%
1.93
+190.66%
0.66
Financing Cash Flow
1.99
-1.87%
2.03
-39.15%
3.33
+341.00%
-1.38
Cash Flow From Continuing Financing Activities
1.99
-1.87%
2.03
-39.15%
3.33
+341.00%
-1.38
Net Issuance Payments Of Debt
2.20
-10.92%
2.47
-31.48%
3.61
+367.73%
-1.35
Issuance Of Debt
11.67
-1.36%
11.83
-3.65%
12.28
+117.72%
5.64
Repayment Of Debt
-9.46
-1.17%
-9.36
-7.94%
-8.67
-24.06%
-6.99
Long Term Debt Issuance
2.43
+19.79%
2.03
+116.22%
0.94
+4585.00%
0.02
Long Term Debt Payments
-0.07
+70.78%
-0.24
+16.49%
-0.29
+79.42%
-1.41
Net Long Term Debt Issuance
2.36
+32.14%
1.78
+176.01%
0.65
+146.34%
-1.39
Short Term Debt Issuance
9.24
-5.73%
9.80
-13.55%
11.34
+101.82%
5.62
Short Term Debt Payments
-9.39
-3.08%
-9.11
-8.79%
-8.38
-50.31%
-5.57
Net Short Term Debt Issuance
-0.15
-122.17%
0.69
-76.71%
2.96
+6341.30%
0.05
Net Other Financing Charges
-0.21
+52.13%
-0.45
-61.23%
-0.28
-688.57%
-0.04
Changes In Cash
-1.63
-241.84%
-0.48
-127.25%
1.75
+137.53%
-4.67
Effect Of Exchange Rate Changes
-0.01
+87.04%
-0.05
-74.19%
-0.03
-146.27%
0.07
Beginning Cash Position
1.74
-23.39%
2.27
+312.70%
0.55
-89.32%
5.16
End Cash Position
0.10
-94.20%
1.74
-23.39%
2.27
+312.70%
0.55
Free Cash Flow
-3.62
-39.33%
-2.60
+19.15%
-3.22
-51.67%
-2.12
Interest Paid Supplemental Data
0.22
+114.42%
0.10
-35.80%
0.16
+52.83%
0.11
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category